Clinical Examination of Metal Free Interdental Brushes
Clinical Efficacy and Patient Acceptance of Metal and Metal-Free Interdental Brushes: A Controlled Prospective Randomized Study
1 other identifier
interventional
39
1 country
1
Brief Summary
The aim of the study was to evaluate the clinical efficacy (Eastman Interdental Bleeding Index, Quigley and Hein) of a novel metal-free interdentalbrush compared to a classig metal-core interdental brush.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
Started Sep 2010
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2011
CompletedFirst Submitted
Initial submission to the registry
April 28, 2012
CompletedFirst Posted
Study publicly available on registry
May 8, 2012
CompletedMay 8, 2012
May 1, 2012
11 months
April 28, 2012
May 7, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
Analysis of the differences between both groups. Measurements in form of Plaque-Index (Quigley und Hein, Tureskey Mod. 1970)
Beginning and after four weeks of use
Secondary Outcomes (1)
Eastman Interdental Bleeding Index, questionnaire of patient acceptance
Beginning and after four weeks of use
Study Arms (2)
metal-free interdental brushes.
EXPERIMENTALmetal-core interdental brushes
ACTIVE COMPARATORInterventions
one time per day
one time per day
Eligibility Criteria
You may qualify if:
- minimum age: 18 years
You may not qualify if:
- allergy against one or more parts of the interdental brushes
- non-treated periodontitis
- soft-tissue changes of the mucosa
- orthodontic treatment
- removable prosthesis
- pregnancy
- anticoagulants
- drugs causing gingivahyperplasia
- indications for antibiotics
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Freiburg Medical Center , Dept of Operative Dentistry and Periodontology
Freiburg im Breisgau, 79106, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Johan P Woelber, Dr.
University of Freiburg
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
April 28, 2012
First Posted
May 8, 2012
Study Start
September 1, 2010
Primary Completion
August 1, 2011
Study Completion
September 1, 2011
Last Updated
May 8, 2012
Record last verified: 2012-05